Clinical Trials Browser

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 × 30 days × Clear all

NCT04522336 2026-03-05

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8